obsolete_sarcoidosis: ['An idiopathic inflammatory disorder characterized by the formation of non-necrotizing epithelioid granulomas which contain giant cells. It usually affects the lungs, lymph nodes, liver, and skin.', 'An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.']
| Name | D3_SARCOIDOSIS |
|---|---|
| Long name | Sarcoidosis |
| Hospital Discharge registry | ICD-10: D86, ICD-9: 135, ICD-8: 135 |
| Cause of Death registry | ICD-10: D86, ICD-9: 135, ICD-8: 135 |
| KELA reimboursements codes | 132 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
| Latin name | Sarcoidosis |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2046 | 1144 | 902 |
| Unadjusted prevalence (%) | 0.94 | 0.93 | 0.96 |
| Mean age at first event (years) | 45.87 | 46.73 | 44.79 |
| Case fatality at 5-years (%) | 1.12 | 0.87 | 1.44 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 4.0 | 4.0 | 4.0 |
| Recurrence at 6 months (%) | 67.50 | 67.40 | 67.63 |
before Sarcoidosis
after Sarcoidosis
Loading survival analyses plot…
Loading survival analyses table…